Literature DB >> 9210984

Factor analysis of the Mayo-Portland Adaptability Inventory: structure and validity.

D L Bohac1, J F Malec, A M Moessner.   

Abstract

Principal-components (PC) factor analysis of the Mayo-Portland Adaptability Inventory (MPAI) was conducted using a sample of outpatients (n = 189) with acquired brain injury (ABI) to evaluate whether outcome after ABI is multifactorial or unifactorial in nature. An eight-factor model was derived which explained 64-4% of the total variance. The eight factors were interpreted as representing Activities of Daily Living, Social Initiation, Cognition, Impaired-Self-awareness/Distress, Social Skills/ Support, Independence, Visuoperceptual, and Psychiatric, respectively. Validation of the Cognition factor was supported when factor scores were correlated with various neuropsychological measures. In addition, 117 patient self-rating total scores were used to evaluate the Impaired Self-awareness/Distress factor. An inverse relationship was observed, supporting this factor's ability to capture the two-dimensional phenomena of diminished self-awareness or enhanced emotional distress. A new subscale structure is suggested, that may allow greater clinical utility in understanding how ABI manifests in patients, and may provide clinicians with a better structure for implementing treatment strategies to address specific areas of impairment and disability for specific patients. Additionally, more precise measurement of treatment outcomes may be afforded by this reorganization.

Entities:  

Mesh:

Year:  1997        PMID: 9210984

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  7 in total

1.  Post-Inpatient Brain Injury Rehabilitation Outcomes: Report from the National OutcomeInfo Database.

Authors:  James F Malec; Jacob Kean
Journal:  J Neurotrauma       Date:  2015-11-19       Impact factor: 5.269

2.  The TBI-CareQOL Measurement System: Development and Preliminary Validation of Health-Related Quality of Life Measures for Caregivers of Civilians and Service Members/Veterans With Traumatic Brain Injury.

Authors:  Noelle E Carlozzi; Michael A Kallen; Robin Hanks; Elizabeth A Hahn; Tracey A Brickell; Rael T Lange; Louis M French; Anna L Kratz; David S Tulsky; David Cella; Jennifer A Miner; Phillip A Ianni; Angelle M Sander
Journal:  Arch Phys Med Rehabil       Date:  2018-09-07       Impact factor: 3.966

3.  The Minimal Clinically Important Difference for the Mayo-Portland Adaptability Inventory.

Authors:  James F Malec; Jacob Kean; Patrick O Monahan
Journal:  J Head Trauma Rehabil       Date:  2017 Jul/Aug       Impact factor: 2.710

4.  New astroglial injury-defined biomarkers for neurotrauma assessment.

Authors:  Julia Halford; Sean Shen; Kyohei Itamura; Jaclynn Levine; Albert C Chong; Gregg Czerwieniec; Thomas C Glenn; David A Hovda; Paul Vespa; Ross Bullock; W Dalton Dietrich; Stefania Mondello; Joseph A Loo; Ina-Beate Wanner
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-17       Impact factor: 6.200

5.  Rasch measurement analysis of the Mayo-Portland Adaptability Inventory (MPAI-4) in a community-based rehabilitation sample.

Authors:  Jacob Kean; James F Malec; Irwin M Altman; Shannon Swick
Journal:  J Neurotrauma       Date:  2011-04-12       Impact factor: 5.269

6.  Understanding Health-Related Quality of Life in Caregivers of Civilians and Service Members/Veterans With Traumatic Brain Injury: Establishing the Reliability and Validity of PROMIS Fatigue and Sleep Disturbance Item Banks.

Authors:  Noelle E Carlozzi; Phillip A Ianni; David S Tulsky; Tracey A Brickell; Rael T Lange; Louis M French; David Cella; Michael A Kallen; Jennifer A Miner; Anna L Kratz
Journal:  Arch Phys Med Rehabil       Date:  2018-06-20       Impact factor: 3.966

7.  Effectiveness of Post-Hospital Intensive Residential Rehabilitation after Acquired Brain Injury: Outcomes of 256 Program Completers Compared to Participants in a Residential Supported Living Program.

Authors:  April R Groff; James Malec; Debra Braunling-McMorrow
Journal:  J Neurotrauma       Date:  2019-09-06       Impact factor: 5.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.